Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Scientific Reports|May 15, 2025
A monocular endoscopic image depth estimation method based on a window-adaptive asymmetric dual-branch Siamese networkNannan Chong, Fan Yang, Kewei WeiJournal of Endocrinological Investigation|July 14, 2025
Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathySimeng Wang, Xinyu Zhang, Nannan Chong, et al.Biochemical and Biophysical Research Communications|December 31, 2024
Network pharmacology, molecular docking, and experimental verification to reveal the mechanism of colquhounia root tablet in the treatment of diabetic nephropathyDandan Chen, Simeng Wang, Zhikang Sun, et al.Diabetology & Metabolic Syndrome|February 7, 2024
Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathwayJingshu Sun, Xinyu Zhang, Simeng Wang, et al.Renal Failure|May 14, 2025
Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expressionDandan Chen, Jianqiang Shu, Xinyu Zhang, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 4, 2025
Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic NephropathyJianqiang Shu, Dandan Chen, Wenzhen Chen, et al.International Immunopharmacology|January 5, 2024
GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathwaysXinyu Zhang, Simeng Wang, Nannan Chong, et al.Pageof 1